Asahi Kasei Medical Co Ltd - Company Review
Asahi Kasei Medical Co Ltd - Company ReviewSummary
Asahi Kasei Medical Co Ltd (Asahi Kasei) a subsidiary of Asahi Kasei Corp is a medical device company which develops, manufacture and commercializes dialysis products. The company’s products include dialysis products, leukocyte reduction filters, therapeutic apheresis products, and virus removal filters. Its dialysis products include dialyser, needle set and blood tubing set; and filters including plasmaflo op, cascadeflo ec, immusorba tr, immusorba ph, plasorba br, rheofilter er, cureflo, and cellsorba ex among others. Asahi Kasei provides products through aps series, rexeed series, vie series, kf-201 series and leoceed series. The company offers products for use in bio-pharmaceutical manufacturing processes. Asahi Kasei is headquartered in Chiyoda-ku, Tokyo, Japan.
This comprehensive company report of Asahi Kasei Medical Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.